Free Trial

Washington Trust Advisors Inc. Raises Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Washington Trust Advisors Inc. raised its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 5.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,970 shares of the industrial products company's stock after acquiring an additional 3,155 shares during the period. Washington Trust Advisors Inc.'s holdings in Xylem were worth $7,522,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Xylem by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after purchasing an additional 303,854 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock valued at $671,623,000 after buying an additional 135,492 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of Xylem by 7.9% in the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after buying an additional 320,500 shares during the period. Invesco Ltd. lifted its stake in Xylem by 9.8% during the 4th quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock worth $465,229,000 after acquiring an additional 359,276 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock worth $435,119,000 after acquiring an additional 301,070 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Up 0.4%

NYSE:XYL traded up $0.57 during trading hours on Thursday, hitting $132.28. The company's stock had a trading volume of 713,729 shares, compared to its average volume of 1,412,310. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $143.50. The company has a current ratio of 1.89, a quick ratio of 1.41 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $32.19 billion, a P/E ratio of 35.56, a price-to-earnings-growth ratio of 2.38 and a beta of 1.12. The stock has a fifty day moving average of $125.21 and a 200-day moving average of $121.91.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. The business had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.04 billion. Xylem had a return on equity of 10.12% and a net margin of 10.54%. The business's revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.90 EPS. On average, equities analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th were given a dividend of $0.40 per share. The ex-dividend date was Thursday, May 29th. This represents a $1.60 annualized dividend and a dividend yield of 1.21%. Xylem's dividend payout ratio is presently 43.01%.

Analyst Ratings Changes

A number of analysts have issued reports on XYL shares. Stifel Nicolaus boosted their price target on shares of Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Citigroup cut their target price on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Royal Bank Of Canada raised their price target on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research report on Wednesday, April 30th. Raymond James Financial upgraded shares of Xylem to a "hold" rating in a research note on Thursday, May 15th. Finally, JPMorgan Chase & Co. assumed coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $143.71.

Check Out Our Latest Analysis on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines